Rory Mullen, Head of BioPharma and Food at IDA Ireland

Q&A: Ire­land bio­phar­ma leader dis­cuss­es the na­tion’s 2022 boost in man­u­fac­tur­ing

The Emer­ald Isle has been of ma­jor in­ter­est to phar­ma man­u­fac­tur­ers for sev­er­al decades now, with gi­ants like Pfiz­er, No­var­tis, and Bay­er call­ing Ire­land home since the 1950s and 1960s.

Ire­land re­turned to the spot­light this year with ex­pan­sion projects and new con­struc­tion projects to­tal­ing hun­dreds of mil­lions of Eu­ros, and, most re­cent­ly, Pfiz­er’s more than $1.2 bil­lion in­vest­ment in its man­u­fac­tur­ing site at Grange Cas­tle in Dublin, mark­ing Pfiz­er’s largest ex­pan­sion in­vest­ment in Ire­land to date.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.